The Role of Natriuretic Peptide Administration in Cardiovascular Surgery-Associated Renal Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 2, 2009, Pages 151-160

  Nigwekar, Sagar U ^a   Hix, John K ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

acute renal failure; cardiac surgery; natriuretic peptides; vascular surgery

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; NATRIURETIC PEPTIDE TYPE C; URODILATIN;

ACUTE KIDNEY FAILURE; ALDOSTERONE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; COCHRANE LIBRARY; CREATININE BLOOD LEVEL; EMBASE; HEMODIALYSIS; HUMAN; INFORMATION RETRIEVAL; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LENGTH OF STAY; MEDICAL INFORMATION; MEDLINE; META ANALYSIS; MORTALITY; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL PROTECTION; SURGICAL PATIENT; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE VOLUME;

ADULT; AGED; ALDOSTERONE; BIOLOGICAL MARKERS; CARDIOVASCULAR SURGICAL PROCEDURES; CREATININE; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MODELS, STATISTICAL; NATRIURETIC PEPTIDES; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 62549112115     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.11.007     Document Type: Article

References (69)

1. Rosner M.H., and Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1 (2006) 19-32
2. Hertzer N.R., Mascha E.J., Karafa M.T., et al. Open infrarenal abdominal aortic aneurysm repair: The Cleveland Clinic experience from 1989 to 1998. J Vasc Surg 35 (2002) 1145-1154
3. Wahlberg E., Dimuzio P.J., and Stoney R.J. Aortic clamping during elective operations for infrarenal disease: The influence of clamping time on renal function. J Vasc Surg 36 (2002) 13-18
4. Chertow G.M., Levy E.M., Hammermeister K.E., et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104 (1998) 343-348
5. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
6. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128 (1998) 194-203
7. Conlon P.J., Stafford-Smith M., White W.D., et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14 (1999) 1158-1162
8. Garwood S. Renal insufficiency after cardiac surgery. Semin Cardiothorac Vasc Anesth 8 (2004) 227-241
9. Thakar C.V., Yared J.P., Worley S., et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int 64 (2003) 239-246
10. Leacche M., Rawn J.D., Mihaljevic T., et al. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol 93 (2004) 353-356
11. Bellomo R., Auriemma S., Fabbri A., et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 2 (2008) 166-178
12. Vesely D.L. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 285 (2003) 167-177
13. Roy D.R. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 25 (1986) 220-225
14. Opgenorth T.J., and Novosad E.I. Atrial natriuretic factor and endothelin interactions in control of vascular tone. Eur J Pharmacol 191 (1990) 351-357
15. Sagnella G.A. Practical implications of current natriuretic peptide research. J Renin Angiotensin Aldosterone Syst 1 (2000) 304-315
16. Gagelmann M., Hock D., and Forssmann W.G. Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (alpha-hANP/CDD-99-126). FEBS Lett 233 (1988) 249-254
17. Sonnenberg H., Honrath U., Chong C.K., et al. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 250 (1986) F963-F966
18. Lainchbury J.G., Burnett Jr. J.C., Meyer D., et al. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs. Am J Physiol Heart Circ Physiol 278 (2000) H33-H40
19. Chen H.H., Cataliotti A., Schirger J.A., et al. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Am J Physiol Regul Integr Comp Physiol 288 (2005) R1093-R1097
20. Elíasdóttir S.B., Klemenzson G., Torfason B., et al. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand 52 (2008) 182-187
21. Rodseth R.N., Padayachee L., and Biccard B.M. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63 (2008) 1226-1233
22. Kentsch M., Drummer C., Gerzer R., et al. Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failure. Eur J Clin Invest 25 (1995) 281-283
23. Allgren R.L., Marbury T.C., Rahman S.N., et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336 (1997) 828-834
24. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 (1999) 1896-1900
25. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 17 (1996) 1-12
26. Alderson P., Green S., and Higgins J.P.T. Analysing and presenting results (2004) Section 8, Cochrane Reviewer's Handbook 4.2.2. The Cochrane Library, Issue 1, 2004. Vol. Updated March 2004, John Wiley & Sons Ltd
27. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
28. Sumi K., Iida H., Yamaguchi S., et al. Human atrial natriuretic peptide prevents the increase in pulmonary artery pressure associated with aortic unclamping during abdominal aortic aneurysmectomy. J Cardiothorac Vasc Anesth 22 (2008) 204-209
29. Wiebe K., Meyer M., Wahlers T., et al. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN:Ularitide). Eur J Med Res 1 (1996) 259-265
30. Bergman A., Odar-Cederlöf I., Westman L., et al. Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 10 (1996) 490-496
31. Brackbill M.L., Stam M.D., Schuller-Williams R.V., et al. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. Ann Pharmacother 41 (2007) 427-432
32. Brenner P., Meyer M., Reichenspurner H., et al. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation. Eur J Med Res 1 (1995) 137-143
33. Chen H.H., Sundt T.M., Cook D.J., et al. Low-dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary bypass surgery: A double-blind placebo-controlled pilot study. Circulation 116 (2007) I134-I138
34. Hayaashi Y., Ohtani M., Sawa Y., et al. Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. J Cardiovasc Pharmacol 42 (2003) 636-641
35. Hayashida N., Chihara S., Kashikie H., et al. Effects of intraoperative administration of atrial natriuretic peptide. Ann Thorac Surg 70 (2000) 1319-1326
36. Mentzer Jr. R.M., Oz M.C., Sladen R.N., et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA Trial. J Am Coll Cardiol 49 (2007) 716-726
37. Meyer M., Wiebe K., Wahlers T., et al. Urodilatin (INN:ularitide) as a new drug for the therapy of acute renal failure following cardiac surgery. Clin Exp Pharmacol Physiol 24 (1997) 374-376
38. Mitaka C., Kudo T., Jibiki M., et al. Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair. Crit Care Med 36 (2008) 745-751
39. Sezai A., Shiono M., Orime Y., et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 69 (2000) 732-738
40. Sezai A., Hata M., Wakui S., et al. Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery: Possibility of postoperative left ventricular remodeling effect. Circ J 70 (2006) 1426-1431
41. Sezai A., Shiono M., Hata M., et al. Efficacy of continuous low-dose human atrial natriuretic peptide given from the beginning of cardiopulmonary bypass for thoracic aortic surgery. Surg Today 36 (2006) 508-514
42. Sezai A., Shiono M., Wakui S., et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J 71 (2007) 1401-1407
43. Sward K., Valsson F., Odencrants P., et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 32 (2004) 1310-1315
44. Tang I.Y., and Murray P.T. Prevention of perioperative acute renal failure: What works?. Best Pract Res Clin Anaesthesiol 18 (2004) 91-111
45. Zacharias M., Gilmore I.C., Herbison G.P., et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 3 (2005) CD003590
46. Roasio A., Lobreglio R., Santin A., et al. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth 22 (2008) 23-26
47. Landoni G., Biondi-Zoccai G.G., Tumlin J.A., et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: A meta-analysis of randomized clinical trials. Am J Kidney Dis 49 (2007) 56-68
48. Landoni G., Biondi-Zoccai G.G., Marino G., et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: A meta-analysis. J Cardiothorac Vasc Anesth 22 (2008) 27-33
49. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
50. Marin-Grez M., Fleming J.T., and Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324 (1986) 473-476
51. Harris P.J., Thomas D., and Morgan T.O. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 326 (1987) 697-698
52. Dillingham M.A., and Anderson R.J. Inhibition of vasopressin action by atrial natriuretic factor. Science 231 (1986) 1572-1573
53. Struthers A.D. Ten years of natriuretic peptide research: A new dawn for their diagnostic and therapeutic use?. BMJ 308 (2004) 1615-1619
54. Hayashi M., Tsutamoto T., Wada A., et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 37 (2001) 1820-1826
55. Takagi G., Kiuchi K., Endo T., et al. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol 36 (2000) 22-30
56. Colucci W.S., Elkayam U., Horton D.P., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 343 (2000) 246-253
57. Mills R.M., LeJemtel T.H., Horton D.P., et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol 34 (1999) 155-162
58. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 287 (2002) 1531-1540
59. Lewis J., Salem M.M., Chertow G.M., et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36 (2000) 767-774
60. Mattson D.L., Lu S., Roman R.J., et al. Relationship between renal perfusion pressure and blood flow in different regions of the kidney. Am J Physiol 264 (1993) R578-R583
61. Riter H.G., Redfield M.M., Burnett J.C., et al. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol 47 (2006) 2334-2335
62. Ali Z.A., Callaghan C.J., Lim E., et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: A randomized controlled trial. Circulation 116 suppl (2007) I98-I105
63. Hashiguchi H., Morooka H., Miyoshi H., et al. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg 101 (2005) 1584-1589
64. Investigators Report New Renal, Mortality and Safety Data From NAPA Trial of NATRECOR(R) (nesiritide). http://www.medicalnewstoday.com/articles/51595.php Accessed August 18, 2008
65. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol 15 (2004) 1597-1605
66. Chertow G.M., Palevsky P.M., and Greene T. Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician. Clin J Am Soc Nephrol 1 (2006) 1124-1127
67. Cohen J. Statistical Power Analysis for the Behavioral Sciences (1988), Lawrence Erlbaum Associates, Hillsdale, NJ
68. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: Report of an initiative to improve acute kidney injury outcomes. Crit Care 11 (2007) R31
69. Coca S.G., Yalavarthy R., Concato J., et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 73 (2008) 1008-1016